HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong Tang Selected Research

Telbivudine

9/2021Efficacy of different nucleoside analog rescue therapies for entecavir-resistant chronic hepatitis B patients.
1/2020Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy.
2/2015The predictive value of early indicators for HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients with Telbivudine treatment for 104 weeks.
11/2014[Effect of human concentration nucleoside transporters 1 and multi-drug resistance protein 4 gene polymorphism on response of chronic hepatitis B to nucleoside analogues treatment].
4/2014The 104-week efficacy and safety of telbivudine-based optimization strategy in chronic hepatitis B patients: a randomized, controlled study.
9/2013The Discovery and Development of a Potent Antiviral Drug, Entecavir, for the Treatment of Chronic Hepatitis B.
4/2013Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil.
1/2012Lamivudine plus adefovir or telbivudine plus adefovir for chronic hepatitis B patients with suboptimal response to adefovir.
12/2011Effect and Predictive Elements for 52 Weeks' Telbivudine Treatment on Naïve HBeAg positive Chronic Hepatitis B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong Tang Research Topics

Disease

78Chronic Hepatitis B
10/2022 - 04/2003
66Neoplasms (Cancer)
06/2022 - 10/2004
54Infections
04/2022 - 11/2008
31Hepatitis B
03/2022 - 07/2005
29Fibrosis (Cirrhosis)
06/2022 - 01/2006
24Inflammation (Inflammations)
01/2022 - 07/2005
21Hepatocellular Carcinoma (Hepatoma)
06/2022 - 03/2005
13Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 06/2005
10Liver Diseases (Liver Disease)
01/2022 - 03/2014
10Liver Failure
01/2020 - 09/2008
9Neoplasm Metastasis (Metastasis)
01/2021 - 01/2002
8Carcinogenesis
01/2022 - 03/2005
8Acute-On-Chronic Liver Failure
11/2021 - 08/2010
8Squamous Cell Carcinoma of Head and Neck
06/2016 - 01/2011
7Virus Diseases (Viral Diseases)
01/2022 - 06/2005
6Hepatitis
03/2022 - 05/2003
6Disease Progression
01/2022 - 03/2011
6Chronic Hepatitis C
01/2020 - 01/2011
6Acute Liver Failure (Fulminant Hepatic Failure)
10/2019 - 12/2012
6Esophageal Squamous Cell Carcinoma
01/2019 - 01/2011
6Lymphatic Metastasis
01/2019 - 01/2011
5Lung Neoplasms (Lung Cancer)
01/2021 - 04/2012
5Obesity
01/2021 - 04/2009
5Tendinopathy (Tendonitis)
03/2020 - 01/2018
4COVID-19
05/2022 - 08/2020
4Bicuspid Aortic Valve Disease
01/2022 - 07/2014
4Aortic Valve Stenosis (Aortic Stenosis)
01/2022 - 11/2015
4Mitral Valve Insufficiency (Mitral Regurgitation)
10/2021 - 03/2010
4Carcinoma (Carcinomatosis)
01/2021 - 01/2014
4Insulin Resistance
01/2021 - 08/2004
4Rupture
04/2020 - 01/2015
4Reperfusion Injury
04/2020 - 01/2013
4Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2020 - 01/2015
4Prostatic Neoplasms (Prostate Cancer)
01/2020 - 02/2016
4End Stage Liver Disease
01/2019 - 08/2010
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2016 - 01/2011
4Body Weight (Weight, Body)
01/2014 - 12/2011
3Fatty Liver
06/2022 - 01/2020
3Hypoxia (Hypoxemia)
04/2022 - 08/2009
3Non-alcoholic Fatty Liver Disease
12/2021 - 12/2014
3Ischemic Stroke
01/2021 - 03/2020
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 10/2019
3Type 2 Diabetes Mellitus (MODY)
01/2021 - 08/2004

Drug/Important Bio-Agent (IBA)

37Hepatitis B e AntigensIBA
06/2021 - 05/2009
35Antiviral Agents (Antivirals)IBA
06/2021 - 06/2009
31Proteins (Proteins, Gene)FDA Link
06/2022 - 01/2002
20entecavirFDA Link
10/2022 - 01/2011
19DNA (Deoxyribonucleic Acid)IBA
03/2022 - 01/2009
19Hepatitis B Surface Antigens (HBsAg)FDA Link
02/2022 - 03/2005
14NucleosidesIBA
09/2021 - 08/2010
14InterferonsIBA
04/2021 - 04/2003
13Alanine Transaminase (SGPT)IBA
06/2021 - 03/2011
12Glucose (Dextrose)FDA LinkGeneric
07/2022 - 08/2004
12Biomarkers (Surrogate Marker)IBA
06/2022 - 04/2003
11CytokinesIBA
01/2022 - 06/2010
11AntigensIBA
01/2021 - 12/2013
11Messenger RNA (mRNA)IBA
03/2020 - 01/2011
9Tenofovir (Viread)FDA Link
03/2022 - 08/2010
9Pharmaceutical PreparationsIBA
03/2022 - 01/2013
9TelbivudineFDA Link
09/2021 - 12/2011
8RNA (Ribonucleic Acid)IBA
01/2022 - 08/2009
8Biological ProductsIBA
12/2021 - 01/2009
8Lamivudine (Epivir)FDA Link
09/2021 - 05/2009
7nasIBA
03/2022 - 11/2011
7NucleotidesIBA
01/2021 - 08/2010
6Aspartate Aminotransferases (Aspartate Transaminase)IBA
05/2022 - 09/2011
6Cisplatin (Platino)FDA LinkGeneric
08/2020 - 02/2015
6adefovirIBA
01/2020 - 01/2011
6Therapeutic UsesIBA
10/2019 - 04/2003
5Triglycerides (Triacylglycerol)IBA
06/2022 - 03/2009
5Transaminases (Aminotransferases)IBA
12/2021 - 01/2017
5CholesterolIBA
12/2021 - 03/2009
5Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 02/2011
5LigandsIBA
08/2020 - 03/2005
5hepatitis B virus X proteinIBA
01/2019 - 05/2005
4Peptides (Polypeptides)IBA
06/2022 - 01/2013
4LipidsIBA
12/2021 - 03/2009
4Citric Acid (Citrate)FDA LinkGeneric
11/2021 - 01/2018
4Ribavirin (Virazole)FDA LinkGeneric
04/2021 - 01/2011
4Long Noncoding RNAIBA
01/2021 - 12/2019
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2020 - 03/2005
4IntegrinsIBA
01/2019 - 01/2013
4Vitamin DFDA LinkGeneric
03/2018 - 12/2014
4adefovir dipivoxil (Hepsera)FDA Link
08/2014 - 10/2009
3Hemoglobins (Hemoglobin)IBA
07/2022 - 12/2011
3C-Reactive ProteinIBA
06/2022 - 07/2005
3oxidized low density lipoproteinIBA
12/2021 - 03/2009
3EnzymesIBA
01/2021 - 01/2021
3Small Interfering RNA (siRNA)IBA
01/2021 - 11/2011
3Caspase 3 (Caspase-3)IBA
01/2021 - 03/2005

Therapy/Procedure

76Therapeutics
06/2022 - 08/2004
12Drug Therapy (Chemotherapy)
01/2021 - 03/2011
11Liver Transplantation
06/2022 - 09/2002
9Transcatheter Aortic Valve Replacement
01/2022 - 07/2014
5Immunotherapy
01/2022 - 12/2019
4Aftercare (After-Treatment)
03/2022 - 07/2005
4Artificial Liver (Bioartificial Liver)
01/2021 - 01/2017
4Intravenous Injections
01/2014 - 06/2012
4Quantum Dots (Quantum Dot)
01/2013 - 01/2011
3Plasma Exchange
01/2021 - 01/2018